Peptide Stack for Stress and Burnout: Selank, DSIP, and BPC-157

Burnout is not a character flaw or a scheduling problem — it is a physiological state of chronic allostatic overload. The HPA (hypothalamic-pituitary-adrenal) axis, which regulates cortisol and the stress response, becomes dysregulated under prolonged psychological and physiological stress. What begins as elevated cortisol eventually flips to cortisol insufficiency. Sleep architecture disintegrates. Inflammatory markers rise. Cognitive function deteriorates.

Conventional recommendations — rest more, stress less — are accurate but incomplete. Peptide therapy can actively support restoration of the HPA axis, normalize GABA-ergic tone, improve sleep architecture, and reduce the gut-brain inflammation that perpetuates burnout physiology.

This guide covers a three-peptide stack using selank, DSIP, and BPC-157, with cycling protocols for sustainable adrenal recovery.

The Physiology of Burnout

Understanding what burnout does biologically is essential for understanding why these peptides help:

Chronic stress → HPA axis dysregulation: Prolonged cortisol elevation downregulates glucocorticoid receptors in the hippocampus and prefrontal cortex, impairing the negative feedback loop. Cortisol becomes unpredictable — sometimes elevated, sometimes blunted.

Sleep disruption: High cortisol at night disrupts melatonin production and reduces slow-wave (deep) sleep. Poor sleep elevates cortisol the next day — a vicious cycle.

GABA deficit: The GABA neurotransmitter system, which mediates calm and relaxation, becomes depleted under chronic stress. This drives the anxious hypervigilance that characterizes burnout.

Gut-brain axis dysfunction: Chronic stress compromises gut barrier integrity, allowing inflammatory signals (LPS, inflammatory cytokines) to reach the brain through the vagus nerve and systemic circulation. This drives neuroinflammation that worsens mood, cognition, and energy.

Inflammatory cascade: Elevated IL-6, TNF-α, and CRP are consistently found in burnout populations and correlate with the cognitive symptoms (brain fog, poor memory) that define the condition.

A comprehensive peptide protocol addresses each of these mechanisms.

Layer 1: Selank (Anxiolytic and HPA Normalization)

Selank is a synthetic heptapeptide developed by the Institute of Molecular Genetics in Russia. It is a modified fragment of tuftsin (a naturally occurring immunopeptide) with added pharmacological stability. Its primary effects are:

• GABA-ergic modulation: Selank potentiates GABA-A receptor activity, producing anxiolytic effects comparable to benzodiazepines but without sedation, tolerance, or withdrawal risk
• BDNF upregulation: Brain-derived neurotrophic factor promotes neuronal plasticity and is chronically low in anxiety and depression. Selank increases BDNF expression in the hippocampus and prefrontal cortex
• Enkephalin stabilization: Selank inhibits the enzymes that break down enkephalins (natural opioid peptides that regulate stress reactivity), extending their anxiolytic effects
• Cortisol normalization: Research suggests selank helps normalize aberrant cortisol rhythms, supporting appropriate diurnal cortisol variation (high in morning, low at night)

Clinical trials in Russia showed selank significantly reduced anxiety scores in patients with generalized anxiety disorder with a safety profile superior to standard anxiolytic medications.

Protocol:

• Dose: 250–750 mcg per day
• Administration: Intranasal (the most common and convenient route) or subcutaneous injection
• Timing: Morning and/or afternoon — avoid evening use if stimulating effects are noted
• Cycle: 4–8 weeks on, 2 weeks off; selank has low addiction potential and no established withdrawal syndrome, but cycling maintains receptor sensitivity

For the full evidence profile, see our selank peptide guide.

Layer 2: DSIP (Sleep Architecture Restoration)

Delta Sleep-Inducing Peptide (DSIP) was discovered in the 1970s when scientists extracted cerebrospinal fluid from sleeping rabbits and injected it into wakeful animals — the recipients fell into deep sleep. DSIP is a naturally occurring neuropeptide that promotes slow-wave (delta) sleep specifically.

In the context of burnout recovery, DSIP is particularly valuable because:

• Slow-wave sleep (stages 3–4) is where the majority of growth hormone secretion occurs
• Delta sleep is when the brain clears metabolic waste products via the glymphatic system
• Restorative sleep directly normalizes the HPA axis — one night of good sleep meaningfully reduces cortisol reactivity
• DSIP has been shown to reduce cortisol and ACTH levels in stressed subjects, suggesting direct HPA axis modulating properties beyond just sleep promotion
• Unlike hypnotics (zolpidem, benzodiazepines), DSIP improves sleep architecture rather than simply sedating

Protocol:

• Dose: 100–600 mcg per evening
• Administration: Subcutaneous injection or intranasal
• Timing: 30–60 minutes before sleep
• Cycle: 4–6 weeks on, 2–4 weeks off; DSIP effects on sleep architecture are cumulative — many users report reduced need over time as their natural sleep regulation improves

See our detailed DSIP peptide guide for reconstitution and use guidance.

Layer 3: BPC-157 (Gut-Brain Axis and Systemic Repair)

BPC-157's inclusion in a stress and burnout stack might seem unexpected — it is best known for tissue repair. But its role in the gut-brain axis makes it essential:

• Gut barrier repair: Chronic stress degrades gut tight junctions, increasing intestinal permeability. BPC-157 restores barrier function, reducing the flow of inflammatory LPS into systemic circulation
• Dopamine normalization: BPC-157 modulates the dopaminergic system in the brain, supporting dopamine receptor sensitivity and potentially addressing the anhedonia (inability to feel pleasure) characteristic of burnout
• Serotonin regulation: It also affects serotonin pathways, supporting mood stability
• Cortisol-stress interactions: BPC-157 has been shown in animal models to reduce stress-induced lesions and protect against cortisol-mediated tissue damage
• Anti-inflammatory: Its systemic reduction of TNF-α and IL-6 addresses the neuroinflammatory component of burnout

The gut-brain connection in burnout is no longer theoretical — research consistently shows that inflammatory gut conditions and burnout co-occur at high rates, and that gut repair interventions improve mood outcomes.

Protocol:

• Dose: 250–500 mcg per day
• Administration: Oral (for gut-first effects) or subcutaneous injection
• Timing: Morning, on an empty stomach (oral), or any time (injectable)
• Cycle: 8–12 weeks; can be used continuously in severe cases

For more on BPC-157, see our complete BPC-157 guide.

Adrenal Support: The Lifestyle Foundation

Peptides accelerate recovery but cannot function in a vacuum. Adrenal and HPA axis restoration requires:

Cortisol rhythm restoration:

• Wake at a consistent time (7–9 AM ideal); cortisol naturally peaks 30–60 minutes after waking — a pattern destroyed in burnout
• Morning bright light exposure (10+ minutes outdoors or bright light box) reinforces circadian cortisol rhythm
• Avoid caffeine for the first 90–120 minutes after waking to allow the natural cortisol awakening response to complete

Nutrition for adrenal function:

• Adequate sodium (adrenal fatigue is associated with low aldosterone and sodium wasting)
• B vitamins, particularly B5 (pantothenic acid) — the adrenal glands have the highest B5 concentration of any tissue
• Magnesium (glycinate or malate) 200–400 mg before bed — the most commonly depleted mineral in chronically stressed individuals
• Avoid prolonged fasting during recovery phases — blood sugar instability stresses the adrenal axis

Exercise recalibration:

• High-intensity training amplifies cortisol stress during burnout recovery — temporarily reduce intensity
• Walking, low-intensity cycling, yoga, and swimming are appropriate during recovery
• Resume high-intensity training gradually after 6–8 weeks of recovery progress

The 8–12 Week Burnout Recovery Protocol

Weeks 1–4 (Foundation):

• Selank: 250 mcg intranasal twice daily (morning and midday)
• DSIP: 200 mcg subcutaneous nightly
• BPC-157: 250 mcg oral or subcutaneous daily
• Lifestyle: Strict sleep schedule, morning light, reduced training intensity, magnesium supplementation

Weeks 4–8 (Active Recovery):

• Selank: Increase to 500 mcg if needed, or maintain at 250 mcg if well-controlled
• DSIP: 200–400 mcg nightly; reduce to 4–5x per week if sleep has normalized
• BPC-157: 500 mcg daily
• Lifestyle: Begin reintroducing moderate exercise; assess cortisol rhythm using salivary cortisol test

Weeks 8–12 (Consolidation):

• Selank: Begin tapering — use only as needed (situationally stressful periods)
• DSIP: 2–3x per week for sleep quality maintenance
• BPC-157: 250 mcg daily as maintenance
• Reassess: Burnout symptom inventory, energy levels, cognitive function

Monitoring Progress

Objective markers to track during the protocol:

• Salivary cortisol 4-point test (morning, noon, afternoon, night): Tracks whether diurnal rhythm is normalizing
• DHEA-S: A marker of adrenal reserve — typically low in burnout; should rise with recovery
• Resting heart rate variability (HRV): Increases as autonomic nervous system balance improves
• Mood and energy journals: Simple daily scoring provides the most sensitive tracking of functional recovery

Frequently Asked Questions

Q: How is selank different from benzodiazepines for anxiety? Benzodiazepines directly bind GABA-A receptors and produce sedation, tolerance, and withdrawal. Selank modulates GABA-ergic tone more broadly and supports the neurotransmitter systems involved in resilience (BDNF, enkephalins). It is non-addictive and non-sedating at standard doses. It is more comparable to an adaptogen with a peptide mechanism than to a pharmaceutical anxiolytic.

Q: Is burnout the same as adrenal fatigue? "Adrenal fatigue" is a contested diagnostic term not recognized in mainstream medicine, but the physiological state it describes — HPA axis dysregulation with blunted cortisol responses — is real and documented. Burnout is the broader syndrome; HPA dysregulation is one of its measurable components.

Q: Can DSIP be used long term? DSIP is generally considered safe for extended use given that it is a naturally occurring neuropeptide. However, cycling (4–6 weeks on, 2 weeks off) is recommended to preserve sensitivity and allow natural sleep regulation to reassert itself. Long-term dependency on any sleep-promoting compound is worth avoiding.

Q: Should I add any other peptides to this stack for depression symptoms? Semax (particularly N-Acetyl Semax Amidate) is a nootropic peptide that upregulates BDNF and supports dopaminergic function — highly relevant for the anhedonia and cognitive fog of burnout. It can be stacked with selank (they have complementary mechanisms). See our semax guide for details.

Q: How long until I feel meaningfully better? Most users report improved sleep quality within 1–2 weeks of DSIP. Selank's anxiolytic effects are often noticeable within the first week of use. The deeper recovery — restored energy, cognitive performance, emotional resilience — typically requires 6–12 weeks of consistent protocol adherence combined with lifestyle changes.